Neopharm Group
Pharmaceutical Manufacturing
Startup Mature Health Tech & Life Sciences Est. 1941
Total Raised
Undisclosed
Mature
Last Round
Undisclosed
Team
4
51-200 employees
Confidence
80/100
News
1
articles
About
Neopharm is a family of companies that engage in the research and development, manufacturing, marketing, sales, and distribution of a broad range of products in the healthcare market in more than 60 countries worldwide. The Neopharm Group operates in three major segments: pharmaceutical, consumer healthcare, and medical devices.
Classification
Sector
Health Tech & Life SciencesMedical DevicesPharma & Medical Biotechnology
Target Customer
Healthcare & Life SciencesHealthcareProvidersLife SciencesBiotechnologyPharmaceuticalsMedical Devices IndustryMedical ProductsMedical Equipment
Business Model
B2BB2C
Tags
pharmaceuticals
News (1)
growth-positive
Amylyx and Neopharm sign licence agreement for ALS therapy
Partners
Details
Product Stage
Released
Employees
51-200
Exact Count
161
Founded
1941
Registrar
512420555
Locations
HaShiloah St 6, Petah Tikva, Israel
Links
Website
LinkedIn
Admin
Last Update
Apr 25, 2025
Verified by
Matan Eblagon
Missing
tags, video or image, funding rounds, markets, not claimed
Team (4)
David Fuhrer
Owner, Chairman & CEO
Founder
Tal Fuhrer
CBO
Shahar Amitai
CIO
Erez Bublil
CSO
Internal
Created by
Matan Eblagon (matane@sncentral.org)
Created
2023-03-19T00:00:00.000Z
Last editor
Matan Eblagon (matane@sncentral.org)